161 related articles for article (PubMed ID: 29320753)
1. Prognostic significance of S100A16 subcellular localization in lung adenocarcinoma.
Kobayashi M; Nagashio R; Saito K; Aguilar-Bonavides C; Ryuge S; Katono K; Igawa S; Tsuchiya B; Jiang SX; Ichinoe M; Murakumo Y; Saegusa M; Satoh Y; Sato Y
Hum Pathol; 2018 Apr; 74():148-155. PubMed ID: 29320753
[TBL] [Abstract][Full Text] [Related]
2. S100A16 is a Prognostic Marker for Lung Adenocarcinomas.
Saito K; Kobayashi M; Nagashio R; Ryuge S; Katono K; Nakashima H; Tsuchiya B; Jiang SX; Saegusa M; Satoh Y; Masuda N; Sato Y
Asian Pac J Cancer Prev; 2015; 16(16):7039-44. PubMed ID: 26514487
[TBL] [Abstract][Full Text] [Related]
3. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
Chen D; Luo L; Liang C
PLoS One; 2018; 13(5):e0197402. PubMed ID: 29746588
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and prognostic significance of nuclear UGDH localization in lung adenocarcinoma.
Hagiuda D; Nagashio R; Ichinoe M; Tsuchiya B; Igawa S; Naoki K; Satoh Y; Murakumo Y; Saegusa M; Sato Y
Biomed Res; 2019; 40(1):17-27. PubMed ID: 30787260
[TBL] [Abstract][Full Text] [Related]
5. Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion.
Tanaka M; Ichikawa-Tomikawa N; Shishito N; Nishiura K; Miura T; Hozumi A; Chiba H; Yoshida S; Ohtake T; Sugino T
BMC Cancer; 2015 Feb; 15():53. PubMed ID: 25884418
[TBL] [Abstract][Full Text] [Related]
6. S100A16 is a prognostic marker for colorectal cancer.
Sun X; Wang T; Zhang C; Ning K; Guan ZR; Chen SX; Hong TT; Hua D
J Surg Oncol; 2018 Feb; 117(2):275-283. PubMed ID: 28876468
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of G6PD expression and localization in lung adenocarcinoma.
Nagashio R; Oikawa S; Yanagita K; Hagiuda D; Kuchitsu Y; Igawa S; Naoki K; Satoh Y; Ichinoe M; Murakumo Y; Saegusa M; Sato Y
Biochim Biophys Acta Proteins Proteom; 2019 Jan; 1867(1):38-46. PubMed ID: 29753088
[TBL] [Abstract][Full Text] [Related]
8. WIF-1 and Ihh Expression and Clinical Significance in Patients With Lung Squamous Cell Carcinoma and Adenocarcinoma.
Zhang Y; Hu C
Appl Immunohistochem Mol Morphol; 2018 Aug; 26(7):454-461. PubMed ID: 27801732
[TBL] [Abstract][Full Text] [Related]
9. High Expression of Krüppel-like Factor 7 Indicates Unfavorable Clinical Outcomes in Patients with Lung Adenocarcinoma.
Niu R; Tang Y; Xi Y; Jiang D
J Surg Res; 2020 Jun; 250():216-223. PubMed ID: 32092599
[TBL] [Abstract][Full Text] [Related]
10. Correlated low IGF2BP1 and FOXM1 expression predicts a good prognosis in lung adenocarcinoma.
Huang H; Wang D; Guo W; Zhuang X; He Y
Pathol Res Pract; 2019 Jul; 215(7):152433. PubMed ID: 31085008
[TBL] [Abstract][Full Text] [Related]
11. Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer.
Xu XY; Lin N; Li YM; Zhi C; Shen H
Pathol Res Pract; 2013 Jun; 209(6):345-52. PubMed ID: 23602236
[TBL] [Abstract][Full Text] [Related]
12. ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma.
Zheng YZ; Ma R; Zhou JK; Guo CL; Wang YS; Li ZG; Liu LX; Peng Y
Sci Rep; 2016 Nov; 6():36447. PubMed ID: 27830754
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinoma.
Hashiguchi T; Miyoshi H; Nakashima K; Yokoyama S; Matsumoto R; Murakami D; Mitsuoka M; Takamori S; Akagi Y; Ohshima K
Hum Pathol; 2017 May; 63():157-164. PubMed ID: 28322854
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of IMMT expression in surgically-resected lung adenocarcinoma.
Hiyoshi Y; Sato Y; Ichinoe M; Nagashio R; Hagiuda D; Kobayashi M; Kusuhara S; Igawa S; Shiomi K; Goshima N; Murakumo Y; Saegusa M; Satoh Y; Masuda N; Naoki K
Thorac Cancer; 2019 Nov; 10(11):2142-2151. PubMed ID: 31583841
[TBL] [Abstract][Full Text] [Related]
15. Elevated FAM83A expression predicts poorer clincal outcome in lung adenocarcinoma.
Zhang J; Sun G; Mei X
Cancer Biomark; 2019; 26(3):367-373. PubMed ID: 31594212
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic study of visceral pleural invasion by pulmonary adenocarcinoma with tumor size ≤3 cm].
Chen TY; Ma HW; Jin RR; Xu C; Hua HJ; Song GX; Zhang WM; Zhang ZH
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):553-558. PubMed ID: 28810296
[No Abstract] [Full Text] [Related]
17. Prognostic significance of IFITM1 expression and correlation with microvessel density and epithelial-mesenchymal transition signature in lung adenocarcinoma.
Koh YW; Han JH; Jeong D; Kim CJ
Pathol Res Pract; 2019 Jul; 215(7):152444. PubMed ID: 31079850
[TBL] [Abstract][Full Text] [Related]
18. Proteomic Analyses Identify Differentially Expressed Proteins and Pathways Between Low-Risk and High-Risk Subtypes of Early-Stage Lung Adenocarcinoma and Their Prognostic Impacts.
Zhou J; Liu B; Li Z; Li Y; Chen X; Ma Y; Yan S; Yang X; Zhong L; Wu N
Mol Cell Proteomics; 2021; 20():100015. PubMed ID: 33508502
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Prognostic Significance of Glutathione Peroxidase 2 in Lung Adenocarcinoma.
Hashinokuchi A; Matsubara T; Ono Y; Shunichi S; Matsudo K; Nagano T; Kinoshita F; Akamine T; Kohno M; Takenaka T; Oda Y; Yoshizumi T
Ann Surg Oncol; 2024 Jul; 31(7):4822-4829. PubMed ID: 38461192
[TBL] [Abstract][Full Text] [Related]
20. Identification of relevant prognostic values of cytokeratin 20 and cytokeratin 7 expressions in lung cancer.
Luo HT; Liang CX; Luo RC; Gu WG
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28827446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]